Complete Story
 

06/15/2017

NCCN has endorsed the Hematology/Oncology Pharmacy Association (HOPA) position statement on Dose Rounding of Biologic and Cytotoxic Anticancer Agents

NCCN has endorsed the Hematology/Oncology Pharmacy Association (HOPA) position statement on Dose Rounding of Biologic and Cytotoxic Anticancer Agents.
For more information and to access the HOPA position statement, please visit https://www.nccn.org/OrderTemplates/PDF/HOPA.pdf
 

Printer-Friendly Version